Compare BOX & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BOX | AMRX |
|---|---|---|
| Founded | 2005 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.4B | 3.7B |
| IPO Year | 2014 | 2018 |
| Metric | BOX | AMRX |
|---|---|---|
| Price | $24.64 | $11.91 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 4 |
| Target Price | ★ $35.57 | $14.75 |
| AVG Volume (30 Days) | ★ 2.4M | 1.9M |
| Earning Date | 03-03-2026 | 05-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 157.89 |
| EPS | ★ 0.58 | 0.22 |
| Revenue | ★ $506,142,000.00 | N/A |
| Revenue This Year | $9.41 | $6.40 |
| Revenue Next Year | $8.15 | $6.54 |
| P/E Ratio | ★ $42.51 | $53.66 |
| Revenue Growth | ★ 26.98 | N/A |
| 52 Week Low | $21.61 | $6.69 |
| 52 Week High | $38.80 | $15.42 |
| Indicator | BOX | AMRX |
|---|---|---|
| Relative Strength Index (RSI) | 49.56 | 31.31 |
| Support Level | $23.70 | $11.55 |
| Resistance Level | $33.30 | $12.12 |
| Average True Range (ATR) | 0.77 | 0.44 |
| MACD | 0.05 | -0.11 |
| Stochastic Oscillator | 29.13 | 8.92 |
Box is a cloud-based content management platform that provides storage and workflow collaboration services for enterprise customers. The firm was founded in 2005 as a file, sync, and share provider. Over time, it built out and acquired workflow and security tools to evolve the pure-play FSS business into a content management business. Most recently, Box has been pursuing an AI-powered, intelligent content management strategy that can allow for metadata extraction and workflow automation.
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.